# 1. Financial Performance ## A. Key Figures * **Total Revenue:** **₹458 Cr** consolidated (+8%) · **₹447 Cr** stand-alone * **EBITDA:** **₹52 Cr** consolidated & stand-alone (+40%) * **Net Profit:** **₹9.53 Cr** consolidated · **₹10.34 Cr** stand-alone * **EBITDA Margin:** **11%** current · **10–12%** current range ## B. Revenue Growth * **Solid Top-Line Expansion:** Revenue growth at 8% YoY reflects resilient demand and pricing strength despite stable volumes. * **Operational Leverage:** EBITDA surged **40% YoY** on flat turnover, indicating improved operating efficiency and cost discipline. ## C. EBITDA & Margins * **Margin Recovery Underway:** Current EBITDA margin of **11%** reflects healthier operating conditions, though still below historical peaks of **18–20%** seen during industry upcycles. * **Cyclical Sensitivity Persists:** Margins remain exposed to global macro shocks; long-term normalization expected in the **10–12%** range, with upside only in exceptional market conditions. ## D. Profit After Tax * **Divergence in Stand-Alone vs. Consolidated PAT:** Consolidated net profit significantly higher than stand-alone due to **INR19 Cr** in non-operating contributions from subsidiaries. * **Other Income Clarity:** Quarterly other income of **₹2–4 Cr** stems from interest on **~₹60 Cr** in deposits, including **₹40–45 Cr** with banks and **₹15 Cr** with utilities, yielding a normalized return. ## E. Balance Sheet * **Debt Profile Stable:** Total term debt of **₹507 Cr** includes **₹350 Cr** for working capital, with **₹120 Cr** repayment scheduled, signaling manageable near-term obligations. * **Cost of Debt Anchored:** Interest expense expected to remain stable as cost of debt holds in the **5–9%** range, supporting predictable financing costs. --- # 2. Product & Segment Performance ## A. Key Figures * **Q1 FY'26 Revenue:** **₹150 Cr** Dye Intermediates (-4%) · **₹122 Cr** Dyestuff (-10%) · **₹45 Cr** Basic Chemicals (+15% YoY, +139% QoQ) * **Q1 FY'26 Revenue:** **₹84 Cr** Chlor Alkali (+8% YoY, -8% QoQ) · **₹13 Cr** Benzene Derivatives * **Production Volume:** **20,557 MT** Chlor Alkali (standalone) ## B. Dyestuff & Intermediates * **Volume-Driven Decline:** Dye Intermediates revenue decline attributed to **400 MT volume loss** from beta naphthol plant shutdown, despite stable captive consumption of **40% of output**. * **Pricing Pressure:** Both Dyestuff and Dye Intermediates faced **downward price realizations** due to lower raw material costs (e.g., aniline, ethylene), with H acid and Vinyl Sulphone prices stabilizing near **₹503** and **₹247**, respectively. ## C. Basic Chemicals * **Strong Recovery:** Basic Chemicals posted robust YoY and sharp QoQ revenue growth on the back of higher sulfur input and output prices, supported by increased volumes and **40% internal consumption** for dye intermediates. ## D. Chlor Alkali * **Stable Operations:** Chlor Alkali revenue growth YoY offset by QoQ decline; caustic soda volumes and prices remained stable, with management targeting **90–95% capacity utilization** in coming quarters. * **TCCA Early-Stage Contribution:** TCCA generated **₹2 Cr** in revenue at a production value of **₹187,000 per MT**, though margins remain under pressure. ## E. Benzene & Derivatives * **Restarted Operations:** Benzene derivatives at Saykha resumed full-quality production in Q1, now contributing to top line, with **20% sold commercially** and the remainder (MCB) used internally. * **Margin Challenges Ahead:** Benzene and TCCA are not yet margin-accretive due to **intense competition and sluggish demand**, but sequential improvements expected as sales ramp. * **Reduced Textile Dependence:** Revenue mix shift continues, with declining exposure to textile clients (e.g., Trident, Arvind) amid expansion into chlor-alkali, TCCA, and benzene-based businesses. --- # 3. Capacity & Utilization ## A. Key Figures * **Production Volume:** **6,892 MT** Dye Intermediates · **3,741 MT** Dyestuff · **56,731 MT** Basic Chemicals * **PNCB & ONCB Production:** **1,850 MT** (20% capacity utilization) * **MCB Plant Utilization:** **30%** current, expected to exceed **70% by Q3** and reach **~80% by Q4** * **Sener Boya Loss:** **₹1.45 Cr** due to hyperinflation (AS 29) ## B. Plant Utilization Rates * **Low Benzene Derivatives Utilization:** PNCB and ONCB production operating at only 20% of capacity, reflecting weak demand or strategic output management. * **Inventory Discipline:** No inventory buildup despite lower offtake, with proactive management to avoid fund blockage. ## C. MCB & Downstream Output * **MCB Plant Idle Strategically:** First-stage MCB plant not operated due to low utilization and favorable market prices for third-party procurement. * **Product Conversion Strategy:** Company opting to internally convert externally sourced MCB into higher-value products instead of direct sales. ## D. TCCA Production Resumption * **TCCA Resumption Imminent:** Production restart expected within 1–2 months as imported stock nears depletion and inventory normalization progresses. * **Margin Recovery Signal:** Resumption of captive TCCA production anticipated to boost margins significantly. --- # 4. Geography & Export Mix ## A. Key Figures * **Export Revenue Share:** **22%** of total revenue (last quarter) · **B. S. Exports:** **~1%** of total revenue * **TCCA Price Increase:** **INR 50–60** rise to ~**INR 160** post-ADD ## B. Export Dynamics & Market Positioning * **Global Supplier Shift:** Indian suppliers increasingly favored as global partners, enhancing export growth potential. * **Minimal Tariff Risk:** U.S. export exposure negligible at ~1%, insulating company from adverse tariff impacts. * **Domestic Market Opportunity:** TCCA pricing reset post-ADD creates favorable conditions for capturing a **sizable share of the Indian market** within 1–2 months. --- # 5. Strategic Initiatives ## A. Key Figures * **Land Sale Value:** **₹5 Cr** (ex-GST, duties, fees) * **Total Rajpura Land Holding:** **125 acres** (plant on 50 acres) * **Surplus Land Post-Sale:** **62 acres** available for future expansion ## B. Land Sale & Expansion * **Strategic Land Monetization:** Sale of 8 acres at Rajpura is a **business-aligned move** to enable pipeline-based chlorine supply, reducing logistical risks for a neighboring consumer. * **No Impact on Growth Plans:** Divestment from surplus land (62 acres retained post-sale) preserves full capacity for **future chlor-alkali debottlenecking** and new chemical units. * **Project Drag on Margins:** Saykha’s Benzene downstream project continues to weigh on profitability due to **increased overheads**, with minimal revenue contribution in the quarter. ## C. Chlorine Off-take Development * **Off-take Security as Growth Enabler:** Securing new chlorine buyers—like the recently operationalized one—is **critical for future expansion**, given transport constraints. * **Top-Line Support from Stable Supply:** Off-take agreement with Shivtek expected to deliver **material revenue uplift** through assured demand, countering weak pricing trends. ## D. Debt Reduction Plan * **Asset-Led Deleveraging:** Debt reduction to continue via **non-core asset sales**, including portions of Vatva and a Punjab facility, with proceeds ring-fenced for repayment. * **Sustained Deleveraging Trajectory:** Company targets **further term debt reduction next year**, reinforcing balance sheet discipline. --- # 6. Risks & Market Conditions ## A. Key Figures * Chlorine Prices: INR1,500–2,000/ton negative in North India · Previously INR500–6,000/ton negative, up to INR10,000 in Gujarat * **Sulfur Price:** **INR27,000/ton** · **Sulfuric Acid Price:** **INR12,000/ton** ## B. Chlorine Pricing Pressure * **Antidumping Duty Lag:** Benefit from **TCCA antidumping duty** not yet realized due to high prior import volumes; positive impact on **top and bottom lines** expected in **Q3 and Q4 FY'26**. * **Structural Chlorine Challenge:** Despite four adjoining chlorine-consuming units, **Rajpura chlor-alkali plant continues to face disposal bottlenecks**, with negative pricing reflecting oversupply dynamics. * **Volume Disposal Over Price:** Primary constraint remains **securing reliable off-take for large chlorine volumes**, underscoring strategic value of dedicated buyers like Shivtek. ## C. Input Cost Volatility * **Raw Material Relief:** Declines in **naphthalene and aniline oil prices** have eased input costs for Dye Intermediates, supporting margin stability despite soft product pricing. * **Stable Sulfur Chain:** **Sulfur and sulfuric acid prices** remain flat QoQ with **no material margin impact**, indicating cost predictability in key feedstocks. --- # 7. Guidance & Outlook ## A. Key Figures * **Benzene Plant Revenue (FY26):** **₹100 Cr** (revised down from ₹150 Cr) * Benzene Revenue (FY26): ₹100 Cr at ~80% capacity (up to ₹300 Cr potential) * **Group Revenue (FY26):** **₹1,900 Cr** expected (±5%, potential >₹1,950 Cr) * **Group Revenue (FY27):** **₹2,000–2,100 Cr** projected * **Operating Income (FY26):** **₹35 Cr** projected * **Net Profit (FY27):** **₹70–80 Cr** expected (7%–8% ROE) * **Target EBITDA Margin:** **12%–13%** (up from current 10%–11%) * Debt/EBITDA Target: 2.5x long-term ## B. Revenue Outlook & Drivers * **Downward Revision on Benzene:** FY26 benzene revenue scaled back due to project delays, though **full-capacity run-rate of ₹300–350 Cr** remains intact for FY27. * **Group Sales Momentum:** On track to meet consolidated **₹1,900 Cr** revenue target with upside potential, supported by **INR450 Cr quarterly run rate** and incremental volume ramp. * **Seasonal Uptick Expected:** **TCCA sales set to rise in Q3–Q4** as prior inventory constraints ease. ## C. Margin & Profitability Trajectory * **Margin Expansion in Sight:** Blended EBITDA margin expected to improve by **a couple of percentage points** over current levels within 3–6 months, driven by higher utilization (70%–80%). * **Path to Profitability:** Targeted margin expansion to **12%–13%** underpins projected **net profit of ₹70–80 Cr** and **7%–8% ROE** in FY27. ## D. Capital Allocation & Strategic Priorities * **Capex Discipline:** No major capital outlays planned over the next two years; focus shifts to **optimizing existing assets** and improving returns. * **ROE and Deleveraging Focus:** Strategic emphasis on **debt reduction**, capacity utilization, and operational efficiency to restore **sustainable profitability** and achieve **5x debt/EBITDA**.